Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.31B |
| 2 |
GSK
GSK
|
+$624M |
| 3 |
Meta Platforms (Facebook)
META
|
+$609M |
| 4 |
UnitedHealth
UNH
|
+$335M |
| 5 |
Microsoft
MSFT
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
| 2 |
Toronto Dominion Bank
TD
|
+$216M |
| 3 |
GE Aerospace
GE
|
+$195M |
| 4 |
CF Industries
CF
|
+$193M |
| 5 |
Mondelez International
MDLZ
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.73% |
| 2 | Energy | 8.89% |
| 3 | Industrials | 8.57% |
| 4 | Technology | 7.69% |
| 5 | Communication Services | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
2601
DELISTED
Exact Sciences
EXAS
| $2.24M | ﹤0.01% |
42,684
-201,138
| -82% | -$10.7M |
|
2602
Brinker International
EAT
$10.2B
| $2.24M | ﹤0.01% |
57,646
+16,954
| +42% | +$585K |
|
2603
PUT
Phillips 66
PSX
$93.2B
| $2.23M | ﹤0.01% |
22,100
| – | – |
|
2604
PUT
United Parks & Resorts
PRKS
$2.04B
| $2.23M | ﹤0.01% |
164,200
| – | – |
|
2605
CALL
Western Digital
WDC
$175B
| $2.23M | ﹤0.01% |
37,044
+32,943
| +803% | +$2.12M |
|
2606
Invesco S&P MidCap Low Volatility ETF
XMLV
$749M
| $2.22M | ﹤0.01% |
49,019
-2,013
| -4% | -$91.2K |
|
|
2607
United Parks & Resorts
PRKS
$2.04B
| $2.22M | ﹤0.01% |
163,789
+7,677
| +5% | +$95.5K |
|
2608
US Commodity Index
USCI
$375M
| $2.21M | ﹤0.01% |
51,911
-2,103
| -4% | -$85.9K |
|
2609
iShares S&P GSCI Commodity-Indexed Trust
GSG
$940M
| $2.21M | ﹤0.01% |
135,594
+6,167
| +5% | +$95.5K |
|
|
ANDV
2610
PUT
DELISTED
Andeavor
ANDV
| $2.21M | ﹤0.01% |
19,300
| – | – |
|
2611
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.38B
| $2.2M | ﹤0.01% |
21,963
+4,280
| +24% | +$432K |
|
2612
Helmerich & Payne
HP
$4.42B
| $2.2M | ﹤0.01% |
34,067
-16,223
| -32% | -$909K |
|
2613
iShares US Healthcare Providers ETF
IHF
$1.27B
| $2.2M | ﹤0.01% |
70,145
-154,840
| -69% | -$4.66M |
|
2614
BlackRock Health Sciences Trust
BME
$570M
| $2.19M | ﹤0.01% |
60,106
+6,243
| +12% | +$226K |
|
2615
CALL
Cameco
CCJ
$42.6B
| $2.19M | ﹤0.01% |
237,500
+200,000
| +533% | +$1.87M |
|
2616
CALL
AbbVie
ABBV
$441B
| $2.19M | ﹤0.01% |
22,600
-77,700
| -77% | -$7.32M |
|
2617
CALL
Aflac
AFL
$60.9B
| $2.19M | ﹤0.01% |
+49,800
| New | +$2.13M |
|
2618
NovoCure
NVCR
$1.97B
| $2.18M | ﹤0.01% |
108,035
+100,591
| +1,351% | +$1.94M |
|
2619
CALL
Fluor
FLR
$7B
| $2.18M | ﹤0.01% |
+42,200
| New | +$1.96M |
|
|
AMED
2620
DELISTED
Amedisys
AMED
| $2.17M | ﹤0.01% |
41,263
+15,382
| +59% | +$811K |
|
2621
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.1B
| $2.17M | ﹤0.01% |
66,013
+58,410
| +768% | +$1.95M |
|
2622
Invesco Trust for Investment Grade New York Municipals
VTN
$163M
| $2.17M | ﹤0.01% |
157,786
-11,499
| -7% | -$157K |
|
|
SGI
2623
Somnigroup International
SGI
$13.9B
| $2.17M | ﹤0.01% |
138,176
+22,720
| +20% | +$347K |
|
2624
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
| $2.16M | ﹤0.01% |
52,024
+7,589
| +17% | +$303K |
|
2625
Huntington Ingalls Industries
HII
$12.9B
| $2.16M | ﹤0.01% |
9,157
-3,991
| -30% | -$941K |
|
Similar funds
Royal Bank of Canada's Q4 2017 Portfolio in Review
As of Q4 2017, Royal Bank of Canada held 7,447 positions worth $228B, up 9.4% from $208B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $9.66B of net new capital in Q4 2017, opening 331 new positions and adding to 2,461 existing holdings. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $611M trimmed.
- Royal Bank of Canada's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $2.31B increase.
- Royal Bank of Canada's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $611M.
- Royal Bank of Canada fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $144M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $228B portfolio in Q4 2017.
- Royal Bank of Canada opened 331 new positions and closed 486 in Q4 2017.
- Royal Bank of Canada's portfolio value rose 9.4% quarter-over-quarter to $228B.
Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.